Steven Cohen Opti Nose, Inc. Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.63 - $2.02 $488 - $606	300 New	300 $0
Q4 2018 Feb 14, 2019	SELL	$5.84 - $11.92 $904,399 - $1.85 Million	-154,863 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.43 - $29.76 $1.92 Million - $4.61 Million	154,863 New	154,863 $1.93 Million

5.29M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $440M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.